Published in Ophthalmology on February 01, 2005
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) (2010) 1.29
Which treatment is best for which AMD patient? Br J Ophthalmol (2006) 1.13
Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Triple therapy for neovascular age-related macular degeneration using single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone. Br J Ophthalmol (2009) 1.07
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol (2006) 0.98
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol (2006) 0.90
Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial. J Ophthalmic Vis Res (2015) 0.86
Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration. BMC Ophthalmol (2007) 0.86
Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation. Int J Ophthalmol (2012) 0.86
Combination of photodynamic therapy and immunomodulation: current status and future trends. Med Res Rev (2008) 0.85
Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2007) 0.83
Macular atrophy after combined intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization. Int J Ophthalmol (2010) 0.82
Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension. Invest Ophthalmol Vis Sci (2015) 0.81
Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration. Jpn J Ophthalmol (2009) 0.81
Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2007) 0.80
Recurrence of choroidal neovascularisation after photodynamic therapy in patients with age-related macular degeneration. Br J Ophthalmol (2007) 0.80
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2010) 0.80
One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation. Jpn J Ophthalmol (2012) 0.79
Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis). Trans Am Ophthalmol Soc (2008) 0.78
Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study. Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients. Graefes Arch Clin Exp Ophthalmol (2010) 0.78
Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Graefes Arch Clin Exp Ophthalmol (2007) 0.78
Combined treatment of photodynamic therapy and bevacizumab for choroidal neovascularization secondary to age-related macular degeneration. Korean J Ophthalmol (2011) 0.78
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks. Clin Ophthalmol (2010) 0.77
Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone. Clin Ophthalmol (2008) 0.76
Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration. Clin Ophthalmol (2008) 0.76
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2005) 0.75
Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage. Korean J Ophthalmol (2007) 0.75
Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD. J Ophthalmol (2012) 0.75
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response. Graefes Arch Clin Exp Ophthalmol (2007) 0.75
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina (2006) 3.98
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina (2006) 3.29
Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol (2004) 1.65
Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina (2002) 1.63
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina (2002) 1.60
Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol (2008) 1.60
Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology (2003) 1.53
Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol (2008) 1.20
Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol (2002) 1.09
Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina (2005) 0.96
Retinal angiomatous proliferation in age–related macular degeneration. 2001. Retina (2012) 0.85
Idiopathic polypoidal choroidal vasculopathy (IPCV). 1990. Retina (2012) 0.85
Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Retina (2011) 0.82
Verteporfin infusion-associated pain. Am J Ophthalmol (2002) 0.81
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. 2002. Retina (2012) 0.77
Repair of a grade VI hepatic injury: case report and literature review. J Trauma (2002) 0.75
Large spot transpupillary thermotherapy for occult choroidal neovascularization. Arch Ophthalmol (2005) 0.75
Building of an empire. Retina (2012) 0.75
Percutaneous complete repair of failed mitral valve prosthesis: simultaneous closure of mitral paravalvular leaks and transcatheter mitral valve implantation - single-centre experience. EuroIntervention (2015) 0.75
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF CHORIORETINAL LESIONS DUE TO IDIOPATHIC MULTIFOCAL CHOROIDITIS. Retina (2016) 0.75
Neutrophil margination as a possible mechanism for verteporfin infusion-associated pain. Am J Ophthalmol (2003) 0.75